Our commitment to our patients is to provide the most advanced treatments for all types of cancers of the blood, including lymphomas.
Clinical research trials represent some of the most advanced treatment options. Click here to learn more.
Lymphomas are blood cancers that develop in the lymphatic system. The lymphatic system is a network of tissues and organs that rid the body of toxins and waste. In addition, the lymphatic system transports infection-fighting white blood cells through the body.
Lymphomas are broadly categorized into two main types: Hodgkin lymphoma and non-Hodgkin lymphoma. Beyond that, there are many different subtypes, especially subtypes of non-Hodgkin lymphoma. Some lymphomas arise from B-lymphocytes, while others arise from T-lymphocytes. Lymphomas are also described by their growth rate; rapidly growing lymphomas are called “aggressive,” whereas slow growing lymphomas are called “indolent.”
Non-Hodgkin Lymphoma is the most common type of lymphoma. The American Cancer Society estimates that 60,000 people are diagnosed with this cancer every year in the United States.
Hodgkin Lymphoma is less common and tends to affect young adults in the prime of their lives… Thanks to remarkable advances in treatment, Hodgkin Lymphoma is now considered one of the most curable cancers. Combination chemotherapy regimens and sometimes radiation therapy are the modalities used to achieve these high cure rates. Targeted drugs and immunotherapy have recently become available for patients with relapsed disease; the role of these new drugs is being investigated in clinical trials. Rocky Mountain Cancer Centers’ experienced hematologists have been leading the way as new discoveries have brought dramatic changes and unprecedented hope for long-term survival to lymphoma patients.
When a patient is diagnosed with lymphoma, physicians often request a CT scan or PET/CT scan to determine where the lymphoma is located in the body. This information helps determine the stage of the lymphoma. RMCC offers state-of-the-art CT and PET/CT machines.
Treatment for both Hodgkin and non-Hodgkin lymphomas may involve a number of different modalities including chemotherapy, radiation therapy, targeted therapies, and immunotherapies.
Rocky Mountain Cancer Centers oncologists are experts at designing the right treatment plan for each patient, and they are committed to partnering with each patient throughout treatment.
RESEARCH AND CLINICAL TRIALS
At Rocky Mountain Cancer Centers, research is a crucial part of our mission. Our researchers have been instrumental in the development of many new therapies for lymphomas, and we are committed to advancing treatment through discovering new drugs.
Currently, we are participating in multiple trials of new and emerging therapies, as well as new ways to use existing therapies more effectively in combination with other treatments.